Psychedelic Business Spotlight: July 30, 2021
This week in psychedelic business news: More psychedelic-assisted therapy clinics, recruitment begins in early DMT trial, and Filament gets more Health Canada love.
This week in psychedelic business news: More psychedelic-assisted therapy clinics, recruitment begins in early DMT trial, and Filament gets more Health Canada love.
The subcommittee’s review is the largest of its kind to be conducted in the state, which legalized psilocybin for therapeutic and medicinal purposes last November.
Republican Tracy Pennycuick and Democrat Jennifer O’Mara are the latest politicians to take notice of the proven therapeutic use of psilocybin.
New study compiles the experiences of 8,629 ayahuasca users from 40 different countries, and results are very promising for the future of psychedelic-assisted therapy.
AOC says she is “undeterred” after her previous effort to change laws drew laughs from congressional colleagues.
This week in psychedelic business news: Psychedelics as a treatment for obesity and TBIs, plus another psychedelic company inches toward listing on NYSE American stock exchange.
The Iranian model, actress and scientist bonds with former NBA star over spiritual experiences with deceased loved ones during psychedelic trips.
The emerging wellness company aims to transform mental health and addiction treatments through the integration of psychedelic medicines and therapies.
This week in psychedelic business news: A generous donation to advance MDMA research, psilocybin for end-of-life anxiety, and provisional patents filed for synthesizing ibogaine.
The state’s Assembly Public Health Committee wants to set legal limits on possession amount, and at least one advocacy organization thinks that’s a problem.
End of content
End of content
By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.